| scholarly article | Q13442814 |
| P50 | author | George Notas | Q42462647 |
| George Kolios | Q42462669 | ||
| P2093 | author name string | E Kouroumalis | |
| I Drygiannakis | |||
| P Manousou | |||
| A Voumvouraki | |||
| H A Papadaki | |||
| K Pyrovolaki | |||
| L Bourikas | |||
| M Koulentaki | |||
| P2860 | cites work | Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver | Q22010826 |
| Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis | Q24293659 | ||
| An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 | Q24303828 | ||
| Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes | Q24336187 | ||
| Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells | Q24563090 | ||
| Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells | Q24563114 | ||
| Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 | Q24647146 | ||
| Mig and IP-10: CXC chemokines that target lymphocytes | Q28305342 | ||
| Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis | Q30437183 | ||
| Recruitment of lymphocytes to the human liver. | Q34116247 | ||
| The role of chemokines in the immunopathology of the liver | Q34118835 | ||
| Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited | Q34146325 | ||
| Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models | Q36767562 | ||
| Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis | Q37087991 | ||
| CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver | Q37714863 | ||
| Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) | Q39859200 | ||
| Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of chemokines. | Q39951498 | ||
| Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping | Q40495285 | ||
| Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. | Q40851124 | ||
| Ciprofloxacin inhibits cytokine-induced nitric oxide production in human colonic epithelium. | Q42501287 | ||
| The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection | Q42513891 | ||
| Pathogenesis of primary biliary cirrhosis: a unifying model | Q42726334 | ||
| CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation | Q42836727 | ||
| Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. | Q45952178 | ||
| Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives | Q46700450 | ||
| The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. | Q52039719 | ||
| Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. | Q53660265 | ||
| CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis. | Q54380949 | ||
| Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia | Q58041641 | ||
| Distinct Roles for CCR4 and CXCR3 in the Recruitment and Positioning of Regulatory T Cells in the Inflamed Human Liver | Q61943219 | ||
| Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro | Q73504637 | ||
| Increased cell apoptosis in bone marrow trephine biopsies and immunomagnetically isolated myeloid progenitor cells in patients with chronic idiopathic neutropenia | Q73773759 | ||
| Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver | Q82612054 | ||
| Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice | Q83179770 | ||
| P433 | issue | 1 | |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P304 | page(s) | 9-15 | |
| P577 | publication date | 2013-04-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid | |
| P478 | volume | 172 |
| Q92294041 | A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice |
| Q37072376 | Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis |
| Q35933236 | Functional and structural features of cholangiocytes in health and disease |
| Q58732635 | Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9 |
| Q55202763 | NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid. |
| Q38342107 | Novel therapeutic targets in primary biliary cirrhosis |
| Q26799419 | Primary biliary cirrhosis: From bench to bedside |
| Q27025680 | Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets |
| Q26827599 | Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis |
| Q50158327 | The molecular basis of immune regulation in autoimmunity |
| Q38496935 | Transitioning from Idiopathic to Explainable Autoimmune Hepatitis |
Search more.